Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GlaxoSmithKline Biologicals (GSK Biologicals), formerly known as SmithKline Beecham Biologicals, is the global vaccine division of GSK. Headquartered in Rixensart, Belgium, the company is one of the world's leading vaccine manufacturers, researching, developing, and producing prophylactic and therapeutic vaccines. Its extensive portfolio includes vaccines against hepatitis A and B, influenza, meningococcal disease, rotavirus, shingles, and cervical cancer. GSK Biologicals leverages advanced technologies, including recombinant DNA, adjuvant systems, and mRNA platforms, to deliver millions of vaccine doses globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SmithKline Beecham Biologicals.